OFFICIAL PUBLICATION OF

by its subsidiary APPco

PDL Practice Alert

Chris Brooker 03/03/2016

Important changes to legislation regarding pseudoephedrine and naloxone On February 1, 2016, the scheduling on Naloxone changed from S4 to S3 for the treatment of opioid overdose. The two current suppliers of Naloxone have to this date not provided S3 packs so this means pharmacists supplying the product need to be aware of several factors

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Doctor title ‘recognition and respect you deserve’

A huge amount of John's comments are outright xenophobic. There is no point trying to reason with someone who thinks…

Siya Etzebeth

Doctor title ‘recognition and respect you deserve’

Still not answering the question. Just building up more strawmen. If you're confident that you are correct then stop lying…

Siya Etzebeth

Doctor title ‘recognition and respect you deserve’

The Guild doesn't "direct" anyone openly but they hold a lot of power and it's either nieve or disingenous to…

John Smith

Doctor title ‘recognition and respect you deserve’

I honestly don’t know why engage with such a childish response but I’ll give it one more go. I said…

John Smith

PDL Practice Alert

Previous Northern flu season a sign for Australia: Terry White Group

Next Clinical tips: osteoarthritis

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Northern flu season a sign for Australia: Terry White Group

Next Clinical tips: osteoarthritis

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.